FDA Green-Lights Clinical Trial For COVID-19 Coronavirus Treatment That ‘Flattens The Curve’ In Patients

Immunotherapy startup Celuarity announced the FDA has cleared its application for an investigational new stem-cell therapy against COVID-19.

Source: Forbes.com Healthcare News - April 2, 2020 Category: Pharmaceuticals Authors: Alex Knapp, Forbes Staff Source Type: news